UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Virtual Reality for Upper Limb Rehabilitation in Subacute and Chronic Stroke: A Randomized Controlled Trial

Archives of physical medicine and rehabilitation, 2018-05, Vol.99 (5), p.834-842.e4

2018

Volltextzugriff (PDF)

The effect of the rehabilitation program on balance, gait, physical performance and trunk rotation in Parkinson’s disease

Aging clinical and experimental research, 2016-12, Vol.28 (6), p.1169-1177

2016

Volltextzugriff (PDF)

Serum albumin level as a predictor of ischemic stroke outcome

Stroke (1970), 2004-06, Vol.35 (6), p.e156-e158

2004

Volltextzugriff (PDF)

Computational models and motor learning paradigms: Could they provide insights for neuroplasticity after stroke? An overview

Journal of the neurological sciences, 2016-10, Vol.369, p.141-148

2016

Volltextzugriff (PDF)

Three-Dimensional Trunk and Lower Limbs Characteristics during Gait in Patients with Huntington's Disease

Frontiers in neuroscience, 2017-10, Vol.11, p.566-566

2017

Volltextzugriff (PDF)

Determination of nitrite/nitrate in human biological material by the simple Griess reaction

Clinica chimica acta, 1998-06, Vol.274 (2), p.177-188

1998

Volltextzugriff (PDF)

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

Lancet neurology, 2021-07, Vol.20 (7), p.526-536

2021

Volltextzugriff (PDF)

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

The New England journal of medicine, 2017-01, Vol.376 (3), p.221-234

2017

Volltextzugriff (PDF)

II genotype of the angiotensin-converting enzyme gene increases the risk for subarachnoid hemorrhage from ruptured aneurysm

Stroke (1970), 2004-07, Vol.35 (7), p.1594-1597

2004

Volltextzugriff (PDF)

Hypercortisolemia in acute stroke is related to the inflammatory response

Journal of the neurological sciences, 2002-04, Vol.196 (1), p.27-32

2002

Volltextzugriff (PDF)

A unique multiplex assay to profile growth factors and cytokines in CSF of MS and ALS patients

The Journal of immunology (1950), 2021-05, Vol.206 (1_Supplement), p.26-26.06

2021

Volltextzugriff (PDF)

Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

Lancet neurology, 2023-05, Vol.22 (5), p.395-406

2023

Volltextzugriff (PDF)

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis

The New England journal of medicine, 2012-09, Vol.367 (12), p.1087-1097

2012

Volltextzugriff (PDF)

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial

The Lancet (British edition), 2012-11, Vol.380 (9856), p.1819-1828

2012

Volltextzugriff (PDF)

Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study

Lancet neurology, 2008-09, Vol.7 (9), p.796-804

2008

Volltextzugriff (PDF)

CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion

Neurology, 2012-03, Vol.78 (10), p.690-695

2012

Volltextzugriff (PDF)

Fibrin clot properties in acute ischemic stroke: relation to neurological deficit

Thrombosis research, 2010-04, Vol.125 (4), p.357-361

2010

Volltextzugriff (PDF)

Gene Expression Profiles in Human Ruptured and Unruptured Intracranial Aneurysms: What Is the Role of Inflammation?

Stroke (1970), 2010-02, Vol.41 (2), p.224-231

2010

Volltextzugriff (PDF)

Vivacity-MG: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Nipocalimab Administered to Adults with Generalized Myasthenia Gravis (2157)

Neurology, 2021-04, Vol.96 (15_supplement)

2021

Volltextzugriff (PDF)

Reflexive and voluntary saccadic eye movements as biomarker of Huntington's Disease

Neurologia i neurochirurgia polska, 2024-01, Vol.58 (3), p.323-330

2024

Volltextzugriff (PDF)

The relation between plasma α-synuclein level and clinical symptoms or signs of Parkinson's disease

Neurologia i neurochirurgia polska, 2018-03, Vol.52 (2), p.243-251

2018

Volltextzugriff (PDF)

Gene Expression Profiling of Blood in Ruptured Intracranial Aneurysms: in Search of Biomarkers

Journal of cerebral blood flow and metabolism, 2013-07, Vol.33 (7), p.1025-1031

2013

Volltextzugriff (PDF)

Depressogenic medications and other risk factors for depression among Polish patients with epilepsy

Neuropsychiatric disease and treatment, 2015-01, Vol.11, p.2509-2517

2015

Volltextzugriff (PDF)

Beta-blockers reduce the risk of early death in ischemic stroke

Journal of the neurological sciences, 2007-01, Vol.252 (1), p.53-56

2007

Volltextzugriff (PDF)

1 – 25 von 218

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(204)
Mit Volltextzugriff
(146)

Publikationsform

Sprache

Englisch
(176)
Polnisch
(43)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Virtual Reality for Upper Limb Rehabilitation in Subacute and Chronic Stroke: A Randomized Controlled Trial

The effect of the rehabilitation program on balance, gait, physical performance and trunk rotation in Parkinson’s disease

Serum albumin level as a predictor of ischemic stroke outcome

Computational models and motor learning paradigms: Could they provide insights for neuroplasticity after stroke? An overview

Three-Dimensional Trunk and Lower Limbs Characteristics during Gait in Patients with Huntington's Disease

Determination of nitrite/nitrate in human biological material by the simple Griess reaction

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

II genotype of the angiotensin-converting enzyme gene increases the risk for subarachnoid hemorrhage from ruptured aneurysm

Hypercortisolemia in acute stroke is related to the inflammatory response

A unique multiplex assay to profile growth factors and cytokines in CSF of MS and ALS patients

Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial

Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study

CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion

Fibrin clot properties in acute ischemic stroke: relation to neurological deficit

Gene Expression Profiles in Human Ruptured and Unruptured Intracranial Aneurysms: What Is the Role of Inflammation?

Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis

Vivacity-MG: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Nipocalimab Administered to Adults with Generalized Myasthenia Gravis (2157)

Reflexive and voluntary saccadic eye movements as biomarker of Huntington's Disease

The relation between plasma α-synuclein level and clinical symptoms or signs of Parkinson's disease

Gene Expression Profiling of Blood in Ruptured Intracranial Aneurysms: in Search of Biomarkers

Depressogenic medications and other risk factors for depression among Polish patients with epilepsy

Beta-blockers reduce the risk of early death in ischemic stroke

Suchergebnisse filtern